1. Home
  2. XENE vs FINV Comparison

XENE vs FINV Comparison

Compare XENE & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • FINV
  • Stock Information
  • Founded
  • XENE 1996
  • FINV 2007
  • Country
  • XENE Canada
  • FINV China
  • Employees
  • XENE N/A
  • FINV N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • FINV Finance: Consumer Services
  • Sector
  • XENE Health Care
  • FINV Finance
  • Exchange
  • XENE Nasdaq
  • FINV Nasdaq
  • Market Cap
  • XENE 2.5B
  • FINV 2.2B
  • IPO Year
  • XENE 2014
  • FINV N/A
  • Fundamental
  • Price
  • XENE $28.85
  • FINV $8.35
  • Analyst Decision
  • XENE Strong Buy
  • FINV Strong Buy
  • Analyst Count
  • XENE 11
  • FINV 2
  • Target Price
  • XENE $54.82
  • FINV $11.55
  • AVG Volume (30 Days)
  • XENE 1.5M
  • FINV 870.0K
  • Earning Date
  • XENE 05-12-2025
  • FINV 05-20-2025
  • Dividend Yield
  • XENE N/A
  • FINV 3.31%
  • EPS Growth
  • XENE N/A
  • FINV 26.19
  • EPS
  • XENE N/A
  • FINV 1.37
  • Revenue
  • XENE $7,500,000.00
  • FINV $1,846,779,164.00
  • Revenue This Year
  • XENE N/A
  • FINV $14.79
  • Revenue Next Year
  • XENE $611.23
  • FINV $10.77
  • P/E Ratio
  • XENE N/A
  • FINV $6.09
  • Revenue Growth
  • XENE N/A
  • FINV 5.40
  • 52 Week Low
  • XENE $26.74
  • FINV $4.63
  • 52 Week High
  • XENE $46.00
  • FINV $11.08
  • Technical
  • Relative Strength Index (RSI)
  • XENE 34.31
  • FINV 47.46
  • Support Level
  • XENE $29.38
  • FINV $8.29
  • Resistance Level
  • XENE $31.74
  • FINV $8.78
  • Average True Range (ATR)
  • XENE 1.34
  • FINV 0.35
  • MACD
  • XENE -0.31
  • FINV -0.01
  • Stochastic Oscillator
  • XENE 7.53
  • FINV 7.90

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

Share on Social Networks: